In a memorandum to Medicare Advantage organizations, the Centers for Medicare & Medicaid Services yesterday announced new flexibility related to the use of step therapy in coverage of Part B services. The agency will allow MA plans to impose step therapy requirements for covered Part B drugs beginning in the 2019 plan year. In addition, the agency will permit those plans that also provide Part D coverage to require that a beneficiary try a Part D drug therapy prior to covering a Part B drug therapy. Federal law allows plans to use some utilization management tools, such as prior authorization; however, the agency has previously not allowed the use of step therapy, nor plans to manage coverage across the Part B and D benefits. The agency will require any plans that take advantage of this new flexibility to provide notice to beneficiaries, as well as additional care coordination services to support access to care. For more see the CMS factsheet.

Headline
The American Medical Association Nov. 17 released its latest annual report on health insurance competition, which found that 95% of commercial markets were…
Headline
The Medicare Part A deductible for inpatient hospital services will increase by $40 in calendar year 2026 to $1,776, the Centers for Medicare & Medicaid…
Headline
The Centers for Medicare & Medicaid Services Nov. 16 issued a proposed rule on program integrity oversight in Medicare, Medicaid, the Children’s Health…
Headline
The Centers for Medicare & Medicaid Services Nov. 5 published a final rule to codify the Medicare Drug Price Negotiation Program beginning in 2029. The…
Headline
The estimated average monthly premium for Medicare Part D stand-alone prescription drug plans is $51 for 2027, a 50% increase from $34 in 2026, for enrollees…
Headline
The Centers for Medicare & Medicaid Services released a proposed rule Oct. 16 seeking to codify regulations that will improve the accuracy of Medicare…